A comparison of complications between ultrasound-guided prostate brachytherapy and open prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 909-913

  Benoit, Ronald M ^a   Naslund, Michael J ^b   Cohen, Jeffrey K ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Complications; Prostate brachytherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; TRANSURETHRAL RESECTION; ULTRASOUND; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COHORT STUDIES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL; URETHRAL OBSTRUCTION; URINARY INCONTINENCE;

EID: 0034237557     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00506-X     Document Type: Article

References (17)

1. Scardino P.T., Carlton C.E. Combined interstitial and external irradiation for prostate cancer. Javadpour N. Principles and management of urologic cancer. 1983;392-408 Williams & Wilkins, Baltimore, MD.
2. Whitmore W.F. Jr, Hilaris B., Grabstald H. Retropubic implantation of iodine 125 in the treatment of prostatic cancer. J Urol. 108:1972;918-920.
3. Koprowski C.D., Berkenstock K.G., Borofski A.M., et al. External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma. Int J Radiat Oncol Biol Phys. 21:1991;955-960.
4. Kuban D.A., Anas E.M., Schellhammer P.F. I-125 implantation for prostate cancer what have we learned 10 years later . Cancer. 63:1989;2415-2420.
5. Morton J.D., Peschel R.E. Iodine-125 implants versus external beam beam therapy for stages A2, B, and C prostate cancer. Int J Radiat Oncol Biol Phys. 14:1988;1153-1157.
6. Fuks Z., Leibel S.A., Wallner K.E., et al. The effect of local control on metastatic dissemination in carcinoma of the prostate Long-term results in patients treated with I-125 implantation . Int J Radiat Oncol Biol Phys. 21:1991;537-547.
7. Porter A.T., Blasko J.C., Grimm P.D., et al. Brachytherapy for prostate cancer. CA Cancer J Clin. 45:1995;165-178.
8. 125Iodine implantation and pelvic lymphadenectomy in the treatment of prostate cancer. J Urol. 121:1979;447-451.
9. Benoit R.M., Naslund M.J., Cohen J.K. Complications after prostate brachytheapy in the Medicare population. Urology. 55:2000;91-96.
10. Holm H.H., Juul N., Pedersen J.F., et al. Transperineal I-125 seed implantation in prostatic cancer guided by transrectal ultrasonagraphy. J Urol. 130:1983;283-286.
11. Kaye K.W., Olson D.J., Lightner D.J., et al. Improved technique for prostate seed implantation combined ultrasound and fluoroscopic guidance . J Endourol. 6:1992;61-66.
12. Blasko J.C., Ragde H., Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether Hypertherm Oncol. 3:1987;131-139.
13. Ragde H., Blasko J.C., Grimm P.D., et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 80:1997;442-453.
14. Stock R.G., Stone N.N., DeWyngaert J.K., et al. Prostate specific antigen findings and biopsy results following interactive ultrasound guided tranperineal brachytherapy for early stage prostate carcinoma. Cancer. 77:1996;2386-2392.
15. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 14:1996;449-453.
16. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 37:1997;559-563.
17. 125iodine implantation for localized prostate cancer using percutaneous approach. J Urol. 153:1995;1020-1025.